Israel Englander Biomea Fusion, Inc. Call Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$4.14 - $15.3 $124,199 - $459,000
30,000 Added 150.0%
50,000 $225,000
Q1 2024

May 15, 2024
SELL
$13.92 - $19.5 $417,600 - $585,000
-30,000 Reduced 60.0%
20,000 $299,000
Q4 2023

Feb 14, 2024
BUY
$8.37 - $19.8 $266,166 - $629,640
31,800 Added 174.73%
50,000 $726,000
Q2 2023

Aug 14, 2023
BUY
$21.66 - $41.8 $394,212 - $760,760
18,200 New
18,200 $399,000

Others Institutions Holding BMEA

# of Institutions
119
Shares Held
17.9M
Call Options Held
978K
Put Options Held
286K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $307M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email